Market Cap 2.86B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 14,848,000
Avg Vol 7,604,734
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 89%
Beta 1.20
Analysts Strong Sell
Price Target $10.75

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Kaykay610
Kaykay610 Aug. 13 at 12:46 AM
$ABCL https://youtu.be/SNlhN6nujIM?is=7iVa9xpWWxIoEvW1 Canada needs a champion
0 · Reply
Kaykay610
Kaykay610 Aug. 13 at 12:16 AM
$ABCL ignore the noise
1 · Reply
Kaykay610
Kaykay610 Aug. 13 at 12:06 AM
$ABCL im not going anywhere until the platform creates a lead molecule for each target,(ion channels, cd3, cd28, tri-specifics, degraders.. etc) 1 down 16 to go and only then will i sell my 6 shares
0 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan Aug. 12 at 11:27 PM
$ABCL sold off 25% this morning at $9.45 and was hoping to buy the same or more under $9, based on last night's trading. It never happened, so I bought back at $9.88. Ooops.
0 · Reply
bdough44
bdough44 Aug. 12 at 10:58 PM
$ABCL Bought at 3.8 and I’m out as of yesterday at 9.79. Looks like I got out a little early. Good luck to all.
2 · Reply
SnoddyTradz
SnoddyTradz Aug. 12 at 10:25 PM
$ABCL Bulls on here bought 10s acting like it really did something 🤣🤣🤣 200m dilution hasn’t dropped yet! It will! So will SP🤣
0 · Reply
BlimpAbove
BlimpAbove Aug. 12 at 9:48 PM
$ABCL $VKTX and? Obviously his actions over there have turned into results. Who’s to say that this won’t happen at Viking now? Ignorant. Extremely
2 · Reply
JohnnyVacs
JohnnyVacs Aug. 12 at 9:45 PM
$VKTX Neil Abuchon must be so happy with his move from $ABCL !!! 😂😂😂😂 Almost gone from Abcellera for 6 months and their stock price has almost tripled. His average in VKTX is $33.50😂😂😂😂😂
0 · Reply
psyxopathis
psyxopathis Aug. 12 at 9:43 PM
$ABCL now that i got banned from all the bears, time to repeat my thesis about the stock and relax 😌. For me Abcl is zero to one company and it requires a lot of patience. I am extremely long and i am not interested to take any profits in the meantime. High risk still, even tho the p2 results imo derisked a lot the platform which is very positive to build the empire ABCL team trying to build. Good luck bulls, we have very long time ahead of us but the limit is literally the sky. ☘️
0 · Reply
SwingTrades1
SwingTrades1 Aug. 12 at 9:35 PM
$ABCL This is how I’m reading the tape: Slow, steady appreciation → solid bases at each level → HV compresses → shorts lose favorable entry points → increasing pressure to cover → potentially stronger upside as resistance gives way.
0 · Reply
Latest News on ABCL
AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 1 day ago

AbCellera announces $200M common stock, warrants offering


AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 1 day ago

AbCellera price target raised to $30 from $12 at Truist


AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 2 days ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 2 days ago

AbCellera Biologics Transcript: Study result


AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 2 days ago

AbCellera Biologics Press release: Study result


AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 2 days ago

AbCellera Biologics Slides: Study result


AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 6 days ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 7 days ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 7 days ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 7 days ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 7 days ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 7 days ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 5 weeks ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 5 weeks ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 5 weeks ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 2 months ago

AbCellera appoints Victor Sandor to board of directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 3 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 9 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


Kaykay610
Kaykay610 Aug. 13 at 12:46 AM
$ABCL https://youtu.be/SNlhN6nujIM?is=7iVa9xpWWxIoEvW1 Canada needs a champion
0 · Reply
Kaykay610
Kaykay610 Aug. 13 at 12:16 AM
$ABCL ignore the noise
1 · Reply
Kaykay610
Kaykay610 Aug. 13 at 12:06 AM
$ABCL im not going anywhere until the platform creates a lead molecule for each target,(ion channels, cd3, cd28, tri-specifics, degraders.. etc) 1 down 16 to go and only then will i sell my 6 shares
0 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan Aug. 12 at 11:27 PM
$ABCL sold off 25% this morning at $9.45 and was hoping to buy the same or more under $9, based on last night's trading. It never happened, so I bought back at $9.88. Ooops.
0 · Reply
bdough44
bdough44 Aug. 12 at 10:58 PM
$ABCL Bought at 3.8 and I’m out as of yesterday at 9.79. Looks like I got out a little early. Good luck to all.
2 · Reply
SnoddyTradz
SnoddyTradz Aug. 12 at 10:25 PM
$ABCL Bulls on here bought 10s acting like it really did something 🤣🤣🤣 200m dilution hasn’t dropped yet! It will! So will SP🤣
0 · Reply
BlimpAbove
BlimpAbove Aug. 12 at 9:48 PM
$ABCL $VKTX and? Obviously his actions over there have turned into results. Who’s to say that this won’t happen at Viking now? Ignorant. Extremely
2 · Reply
JohnnyVacs
JohnnyVacs Aug. 12 at 9:45 PM
$VKTX Neil Abuchon must be so happy with his move from $ABCL !!! 😂😂😂😂 Almost gone from Abcellera for 6 months and their stock price has almost tripled. His average in VKTX is $33.50😂😂😂😂😂
0 · Reply
psyxopathis
psyxopathis Aug. 12 at 9:43 PM
$ABCL now that i got banned from all the bears, time to repeat my thesis about the stock and relax 😌. For me Abcl is zero to one company and it requires a lot of patience. I am extremely long and i am not interested to take any profits in the meantime. High risk still, even tho the p2 results imo derisked a lot the platform which is very positive to build the empire ABCL team trying to build. Good luck bulls, we have very long time ahead of us but the limit is literally the sky. ☘️
0 · Reply
SwingTrades1
SwingTrades1 Aug. 12 at 9:35 PM
$ABCL This is how I’m reading the tape: Slow, steady appreciation → solid bases at each level → HV compresses → shorts lose favorable entry points → increasing pressure to cover → potentially stronger upside as resistance gives way.
0 · Reply
Bullock3000
Bullock3000 Aug. 12 at 8:46 PM
Lots of people disagreed while I was popping the $OPEN bubble. WoW was that profitable. Now it's $ABCL . Don't complain later.
3 · Reply
tiddyy
tiddyy Aug. 12 at 8:43 PM
$ABCL Currently not much value being assigned to the two other mystery programs. If Carl drops some information on ABCL688 we can see +$15 very soon, especially if the addressable market is massive, apparently Phase 1 starts in 2027, so it’s going to be soon This company is still completely undervalued for the data from ABCL635, just wait till the platform starts churning out more programs into the clinical development stage, proper moat being built
1 · Reply
NN555
NN555 Aug. 12 at 8:39 PM
$ABCL https://chatgpt.com/s/t_6a7cd9c7275081919a1cd812256604d3
1 · Reply
Bullock3000
Bullock3000 Aug. 12 at 8:29 PM
$ABCL I just noticed this, curious: "No securities are being offered or sold, directly or indirectly, in Canada or to any resident of Canada."
2 · Reply
Bullock3000
Bullock3000 Aug. 12 at 8:23 PM
$ABCL No offering statement released. Was it undersubscribed, they didnt offer it. What happened?
1 · Reply
psyxopathis
psyxopathis Aug. 12 at 8:14 PM
$ABCL dont squeeze them PLEASE. this time, BURN THEM 🔥
0 · Reply
SwingTrades1
SwingTrades1 Aug. 12 at 8:14 PM
$ABCL Say hello to margin calls and forced short liquidations by brokers.
1 · Reply
cobracollect1
cobracollect1 Aug. 12 at 8:10 PM
0 · Reply
daytwister1
daytwister1 Aug. 12 at 8:10 PM
$ABCL 13-14 $ by next week ? :)
0 · Reply
Vogelito
Vogelito Aug. 12 at 8:05 PM
$ABCL are you alive @tradersunion353 😵‍💫 You were talking about rewarding shareholders and it should go to 10-11 a couple of weeks ago?
1 · Reply
Estimize
Estimize Aug. 12 at 8:03 PM
Wall St is expecting -0.17 EPS for $ABCL Q3 [Reporting 11/10 AMC] http://www.estimize.com/intro/abcl?chart=historical&metric_name=eps&utm_c
0 · Reply
Odoji
Odoji Aug. 12 at 8:02 PM
$ABCL 💉
0 · Reply